| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Gwen Knapp Center for Lupus and Immunology Research, Department of Medicine,
Ben May Institute for Cancer Research, Department of Pathology, and
Howard Hughes Medical Institute, University of Chicago, Chicago, IL 60637; and
§
Pfizer Pharmaceuticals, Groton, CT 06340
Cytotoxic T lymphocyte-associated molecule-4 (CTLA-4) is a cell surface receptor expressed on activated T cells that can inhibit T cell responses induced by activation of the TCR and CD28. Studies with phosphorylated peptides based on the CTLA-4 intracellular domain have suggested that tyrosine phosphorylation of CTLA-4 may regulate its interactions with cytoplasmic proteins that could determine its intracellular trafficking and/or signal transduction. However, the kinase(s) that phosphorylate CTLA-4 remain uncharacterized. In this report, we show that CTLA-4 can associate with the Src kinases Fyn and Lck and that transfection of Fyn or Lck, but not the unrelated kinase ZAP70, can induce tyrosine phosphorylation of CTLA-4 on residues Y201 and Y218. A similar pattern of tyrosine phosphorylation was found in pervanadate-treated Jurkat T cells stably expressing CTLA-4. Phosphorylation of CTLA-4 Y201 in Jurkat cells correlated with cell surface accumulation of CTLA-4. CTLA-4 phosphorylation induced the association of CTLA-4 with the tyrosine phosphatase SHP-2, but not with phosphatidylinositol 3-kinase. In contrast, Lck-induced phosphorylation of CD28 resulted in the recruitment of phosphatidylinositol 3-kinase, but not SHP-2. These findings suggest that phosphorylation of CD28 and CTLA-4 by Lck activates distinct intracellular signaling pathways. The association of CTLA-4 with Src kinases and with SHP-2 results in the formation of a CTLA-4 complex with the potential to regulate T cell activation.
This article has been cited by other articles:
|
|
 |
|
  H. S. W. Lee, M. A. Ostrowski, and S. D. Gray-Owen CEACAM1 Dynamics during Neisseria gonorrhoeae Suppression of CD4+ T Lymphocyte Activation J. Immunol., May 15, 2008; 180(10): 6827 - 6835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Wei, S. da Rocha Dias, H. Wang, and C. E. Rudd CTL-Associated Antigen-4 Ligation Induces Rapid T Cell Polarization That Depends on Phosphatidylinositol 3-Kinase, Vav-1, Cdc42, and Myosin Light Chain Kinase J. Immunol., July 1, 2007; 179(1): 400 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Schneider, E. Valk, S. da Rocha Dias, B. Wei, and C. E. Rudd CTLA-4 up-regulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function PNAS, September 6, 2005; 102(36): 12861 - 12866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. I. Mead, Y. Zheng, C. N. Manzotti, L. C. A. Perry, M. K. P. Liu, F. Burke, D. J. Powner, M. J. O. Wakelam, and D. M. Sansom Exocytosis of CTLA-4 Is Dependent on Phospholipase D and ADP Ribosylation Factor-1 and Stimulated during Activation of Regulatory T Cells J. Immunol., April 15, 2005; 174(8): 4803 - 4811. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pandiyan, D. Gartner, O. Soezeri, A. Radbruch, K. Schulze-Osthoff, and M. C. Brunner-Weinzierl CD152 (CTLA-4) Determines the Unequal Resistance of Th1 and Th2 Cells against Activation-induced Cell Death by a Mechanism Requiring PI3 Kinase Function J. Exp. Med., March 15, 2004; 199(6): 831 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chikuma, J. B. Imboden, and J. A. Bluestone Negative Regulation of T Cell Receptor-Lipid Raft Interaction by Cytotoxic T Lymphocyte-associated Antigen 4 J. Exp. Med., January 6, 2003; 197(1): 129 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Tivol and J. Gorski Re-establishing Peripheral Tolerance in the Absence of CTLA-4: Complementation by Wild-Type T Cells Points to an Indirect Role for CTLA-4 J. Immunol., August 15, 2002; 169(4): 1852 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chikuma and J. A. Bluestone CTLA-4: Acting at the Synapse Mol. Interv., July 1, 2002; 2(4): 205 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Baroja, L. Vijayakrishnan, E. Bettelli, P. J. Darlington, T. A. Chau, V. Ling, M. Collins, B. M. Carreno, J. Madrenas, and V. K. Kuchroo Inhibition of CTLA-4 Function by the Regulatory Subunit of Serine/Threonine Phosphatase 2A J. Immunol., May 15, 2002; 168(10): 5070 - 5078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. I. Kingsley, M. Karim, A. R. Bushell, and K. J. Wood CD25+CD4+ Regulatory T Cells Prevent Graft Rejection: CTLA-4- and IL-10-Dependent Immunoregulation of Alloresponses J. Immunol., February 1, 2002; 168(3): 1080 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Gajewski, F. Fallarino, P. E. Fields, F. Rivas, and M.-L. Alegre Absence of CTLA-4 Lowers the Activation Threshold of Primed CD8+ TCR-Transgenic T Cells: Lack of Correlation with Src Homology Domain 2-Containing Protein Tyrosine Phosphatase J. Immunol., March 15, 2001; 166(6): 3900 - 3907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W.-C. Su, C.-L. Yu, S. J. Burakoff, and Y.-J. Jin Targeting Src Homology 2 Domain-Containing Tyrosine Phosphatase (SHP-1) into Lipid Rafts Inhibits CD3-Induced T Cell Activation J. Immunol., March 15, 2001; 166(6): 3975 - 3982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yi, M. McNerney, and S. K. Datta Regulatory Defects in Cbl and Mitogen-Activated Protein Kinase (Extracellular Signal-Related Kinase) Pathways Cause Persistent Hyperexpression of CD40 Ligand in Human Lupus T Cells J. Immunol., December 1, 2000; 165(11): 6627 - 6634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Saverino, M. Fabbi, F. Ghiotto, A. Merlo, S. Bruno, D. Zarcone, C. Tenca, M. Tiso, G. Santoro, G. Anastasi, et al. The CD85/LIR-1/ILT2 Inhibitory Receptor Is Expressed by All Human T Lymphocytes and Down-Regulates Their Functions J. Immunol., October 1, 2000; 165(7): 3742 - 3755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Masteller, E. Chuang, A. C. Mullen, S. L. Reiner, and C. B. Thompson Structural Analysis of CTLA-4 Function In Vivo J. Immunol., May 15, 2000; 164(10): 5319 - 5327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Cinek, A. Sadra, and J. B. Imboden Cutting Edge: Tyrosine-Independent Transmission of Inhibitory Signals by CTLA-4 J. Immunol., January 1, 2000; 164(1): 5 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Baroja, D. Luxenberg, T. Chau, V. Ling, C. A. Strathdee, B. M. Carreno, and J. Madrenas The Inhibitory Function of CTLA-4 Does Not Require Its Tyrosine Phosphorylation J. Immunol., January 1, 2000; 164(1): 49 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Schneider, M. Martin, F. A. Agarraberes, L. Yin, I. Rapoport, T. Kirchhausen, and C. E. Rudd Cytolytic T Lymphocyte-Associated Antigen-4 and the TCR{zeta}/CD3 Complex, But Not CD28, Interact with Clathrin Adaptor Complexes AP-1 and AP-2 J. Immunol., August 15, 1999; 163(4): 1868 - 1879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Barrat, F. Le Deist, M. Benkerrou, P. Bousso, J. Feldmann, A. Fischer, and G. de Saint Basile Defective CTLA-4 cycling pathway in Chediak-Higashi syndrome: A possible mechanism for deregulation of T lymphocyte activation PNAS, July 20, 1999; 96(15): 8645 - 8650. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
